Health Care & Life Sciences » Pharmaceuticals | Celltrion Pharm Inc.

Celltrion Pharm Inc. | Ownership

Companies that own Celltrion Pharm Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
438,839
1.29%
34,941
0%
07/31/2018
BlackRock Fund Advisors
225,297
0.66%
0
0%
09/06/2018
Dimensional Fund Advisors LP
148,401
0.44%
-2
0%
04/30/2018
Norges Bank Investment Management
141,840
0.42%
141,840
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
64,270
0.19%
0
0%
09/06/2018
Mirae Asset Global Investments Co., Ltd.
31,944
0.09%
8,256
0.02%
04/30/2018
Sjunde AP-fonden
25,008
0.07%
25,008
0%
06/29/2018
Geode Capital Management LLC
23,238
0.07%
0
0%
09/11/2018
Charles Schwab Investment Management, Inc.
21,696
0.06%
0
0%
09/06/2018
Credit Suisse Asset Management (Schweiz) AG
17,370
0.05%
0
0%
07/31/2018

About Celltrion Pharm

View Profile
Address
82 2sandan-ro
Cheongju-si NC 28117
Korea, Republic Of
Employees -
Website http://www.celltrionph.com
Updated 09/14/2018
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs.